| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Tabuteau Herriot serves as a Chief Executive Officer at AXSM. Across recent SEC filings that breaks down to 0 buys and 20 sells. Those positions are worth an estimated $59K at current prices.
Historically, Tabuteau Herriot's trades have earned a below-average insider score of 45/100 across 16 rated trades. On a 3-month view, 18.8% of the rated trades came out ahead, averaging -23.2% over three months.
The biggest single holding is AXSM (~$59K) as Chief Executive Officer. The recent filings there lean toward selling, a net 673,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 49,664 | $212.19 | $10,538,305.04 | -87.3% | - | - | |
| Jul 1, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 49,666 | $240.25 | $11,932,256.50 | -87.3% | -22.7% | - | |
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 49,670 | $241.01 | $11,970,966.70 | -87.3% | -15.4% | - | |
| Feb 2, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 32,410 | $185.60 | $6,015,296.00 | -81.8% | +20.3% | - | |
| Jan 7, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 139,414 | $171.30 | $23,881,617.52 | -95.1% | -1.1% | - | |
| Dec 4, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 79,973 | $145.66 | $11,648,582.34 | -91.7% | +10.8% | - | |
| Nov 5, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 163,939 | $133.07 | $21,815,669.06 | -95.8% | +38.1% | - | |
| Oct 8, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 45,384 | $119.38 | $5,418,059.86 | -86.3% | +44.8% | +43.3% | |
| Sep 16, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 62,880 | $117.08 | $7,361,891.31 | -89.7% | +28.2% | +85.8% |